Long-term risk of irritable bowel syndrome associated with triglyceride-glucose related indices: a large-scale
Haorui Liu1, Si Liu1, Qian Zhang1
1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, 95 Yong'an Road, Xicheng District, Beijing 100050, China.
Background:
Insulin resistance (IR) may play a crucial role in irritable bowel syndrome (IBS) pathogenesis. However, it remains unclear whether triglyceride-glucose (TyG)-related indices, useful biomarkers for assessing IR, are associated with IBS development.
Objectives:
To investigated the link between baseline TyG-related indices and incident IBS.
Design:
A prospective, population-based cohort study.
Methods:
Participants free of IBS with available TyG-related indices (TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), and TyG-body mass index (TyG-BMI)) at enrollment were included (N = 356,904). Primary endpoint was incident IBS. Cox regression was used to evaluate the association between TyG-related indices and IBS.
Results:
During a median 14.6 years of follow-up (5,023,899 person-years), 7381 (2.1%) participants developed IBS. The mean (standard deviation) level of baseline TyG index was 8.7(0.6), with 8.0 (0.2), 8.5 (0.1), 8.9 (0.1), and 9.5 (0.3) in quartile 1-4. Compared with the lowest quartile, the highest quartile of all TyG-related indices was significantly associated with greater risk of incident IBS (TyG hazard ratio (HR) = 1.24, 95% confidence interval (CI): 1.16-1.33, <0.001; TyG-WC HR = 1.25, 95% CI: 1.16-1.34, <0.001; TyG-WHtR HR = 1.24, 95% CI: 1.16-1.33, <0.001; TyG-BMI HR = 1.15, 95% CI: 1.07-1.23, <0.001). Meanwhile, per standardized deviation increment of TyG-related indices were also associated with 6%-9% greater risk of IBS (TyG HR = 1.09, 95% CI: 1.07-1.12; TyG-WC HR = 1.09, 95% CI: 1.07-1.12; TyG-WHtR HR = 1.09, 95% CI: 1.06-1.11; TyG-BMI HR = 1.06, 95% CI: 1.03-1.08). Similar results were observed in various sensitivity analyses and subgroup analysis.
Conclusion:
Higher TyG-related indices are linked to higher risk of incident IBS, highlighting the importance of IR in IBS pathogenesis.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:23Irritable Bowel Syndrome
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...